d-Wise Technologies U.K. has acquired Dootsonic, a privately owned technology organization specializing in the support of the management, analysis and reporting of data from clinical trials.

The acquisition strengthens d-Wise’s European presence and its ability to provide clinical systems implementation and data standards services for global clients, including SASGRID systems for clinical trial programming and analytic teams.

"Together, Dootsonic and d-Wise provide SAS-certified programmers and consultants for on-site collaboration and services, as well as resources for outsourced clinical, IT and biometrics projects. d-Wise also will acquire the Dootsonic office in Manchester, U.K., and relocate d-Wise’s current E.U. facilities from Marlborough, U.K.

Alistair Dootson, the current managing director of Dootsonic, will assume the position of life sciences director, Europe, for d-Wise, and will lead d-Wise’s consulting and service operations in Europe.